MEK1 regulates pulmonary macrophage inflammatory responses and resolution of acute lung injury

Area of Science:

• Immunology
• Cell Biology
• Respiratory Medicine

Background:

• The MEK1/2-ERK1/2 pathway regulates inflammatory responses in lung injury.
• Pharmacologic MEK1/2 inhibitors reduce inflammation in animal models.
• The specific role of myeloid MEK1 in acute lung injury (ALI) resolution is unknown.

Purpose of the Study:

• To investigate the role of myeloid MEK1 in the resolution of lipopolysaccharide-induced ALI (LPS-ALI).
• To assess the activation of the MEK1/2-ERK1/2 pathway in human alveolar macrophages from healthy volunteers and ARDS patients.

Main Methods:

• A murine model of LPS-induced ALI was used.
• Genetic deletion of myeloid Mek1 was achieved using the Cre-floxed system (LysMCre × Mekfl).
• Human alveolar macrophages from healthy volunteers and ARDS patients were analyzed for MEK1/2-ERK1/2 pathway activation.

Main Results:

• Myeloid Mek1 deletion led to a failure in LPS-ALI resolution.
• Alveolar macrophages lacking MEK1 showed increased MEK2 and ERK1/2 activation on day 4 of LPS-ALI.
• Increased MEK1/2-ERK1/2 pathway activation was observed in alveolar macrophages from ARDS patients compared to healthy controls.

Conclusions:

• Myeloid MEK1 plays a critical role in promoting the resolution of LPS-ALI.
• This study reveals that myeloid MEK1 controls the duration of macrophage pro-inflammatory responses.
• Findings suggest the MEK1/2-ERK1/2 pathway's clinical significance in ARDS pathogenesis.